SOFT TISSUE SARCOMA ADULT
Clinical trials for SOFT TISSUE SARCOMA ADULT explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA ADULT trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise in fighting advanced sarcoma
Disease control Recruiting nowThis study tests whether adding an experimental immunotherapy drug called retifanlimab to standard chemotherapy (gemcitabine and docetaxel) can help control advanced soft tissue sarcoma that has spread or cannot be removed by surgery. About 98 adults with this type of cancer will…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:40 UTC
-
New combo aims to halt rare sarcomas
Disease control Recruiting nowThis study tests two drugs, pembrolizumab and cabozantinib, in people with advanced sarcomas that have not responded to standard treatments. The goal is to see if the combination can stop or shrink tumors for at least 6 months. About 119 adults with specific sarcoma types will ta…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 17, 2026 02:39 UTC
-
Proton beams take aim at inoperable sarcomas in new trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. Researchers will also look at bl…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New 3-Week radiation plan aims to cut side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether a personalized, 3-week course of proton or x-ray radiation before surgery can reduce long-term side effects for adults with soft tissue sarcoma. About 110 participants will have two radiation plans made, and a national team will choose the best one for ea…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Sarcoma atlas aims to tailor chemo for 800 patients
Knowledge-focused Recruiting nowThis study looks at tissue and imaging data from 800 people with high-risk soft tissue sarcoma to find ways to personalize chemotherapy. Participants either have surgery alone or chemo before surgery. The goal is to build a tumor atlas and a tool to predict who benefits from chem…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 17, 2026 02:46 UTC